13 November 2023
Cancers | Highly Cited Special Issues on Cancer Drug Development in 2022

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer drug development. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
![]() |
![]() |
“New Diagnostic and Therapeutic Tools Against Multidrug Resistant Tumors” Edited by Prof. Dr. Chiara Riganti, Dr. M. Helena Vasconcelos and Prof. Dr. Catherine Passirani Viewed by 38700+ | Cited by 160+ |
“Tumor Models and Drug Targeting In Vitro” Edited by Dr. Sascha Kopp and Dr. Marcus Krüger Viewed by 18700+ | Cited by 30+ |
![]() |
![]() |
“The Roles of microRNAs in Cancer Aggressiveness and Drug Resistance” Edited by Dr. Bi-Dar Wang and Prof. Dr. Luciane R Cavalli Viewed by 20900+ | Cited by 80+ |
“Cancer Stem Cells (CSCs) in Drug Resistance and Their Therapeutic Implications in Cancer Treatment” Edited by Dr. Peter Van Veldhuizen Viewed by 18000+ | Cited by 50+ |
![]() |
![]() |
“Recent Advances in Drug Therapy for Glioblastoma” Edited by Dr. Juan Manuel Sepúlveda-Sánchez Viewed by 17000+ | Cited by 30+ |
“microRNA and Oxidative Drugs in Cancer Therapy and Prevention” Edited by Prof. Dr. Alberto Izzotti and Prof. Dr. Ming You Viewed by 17300+ | Cited by 30+ |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office